Flexi-VACOP/B followed by high-dose cytoxan (CY) and high dose therapy plus autologous peripheral blood progenitor cell (PBPC) rescue for aggressive NHL with bone marrow involvement at diagnosis

被引:0
|
作者
Congiu, AM [1 ]
Coser, P [1 ]
Leoni, P [1 ]
Salvagno, L [1 ]
Santini, G [1 ]
机构
[1] S Martino Hosp, Dept Haematol, Genova, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:325 / 325
页数:1
相关论文
共 50 条
  • [31] High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma
    Goldschmidt, H
    Hegenbart, U
    Wallmeier, M
    Hohaus, S
    Engenhart, R
    Wannenmacher, M
    Haas, R
    ANNALS OF ONCOLOGY, 1997, 8 (03) : 243 - 246
  • [32] High-dose therapy and peripheral blood progenitor cell transplantation in elderly patients
    Apfelbeck, U
    Eibl, M
    Hoefler, G
    Linkesch, W
    BONE MARROW TRANSPLANTATION, 2001, 27 : S315 - S315
  • [33] High-dose chemotherapy with autologous bone marrow stem-cell rescue in lung cancer
    Basade, MM
    Gulati, SC
    LANCET, 1996, 347 (9005): : 847 - 848
  • [34] Total marrow irradiation (TMI) with helical tomotherapy and peripheral blood progenitor cell rescue (PBPC) following high-dose melphalan (Mel) and PBPC as part of tandem autologous transplant (TAT) for patients with multiple myeloma.
    Somlo, George
    Liu, An
    Schultheiss, Timothy E.
    Frankel, Paul Henry
    Spielberger, Ricardo Tomas
    Popplewell, Leslie
    Zhou, Kenny
    Hawkins, Donna
    Krishnan, Amrita Y.
    Sahebi, Firoozeh
    Parker, Pablo Miguel
    Forman, Stephen J.
    Wong, Jeffrey Y. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [35] High-dose chemotherapy (IQ) with autologous peripheral blood progenitor cell (PBPC) support in patients with advanced breast cancer: Early results
    Constenla, M
    Garcia-Arroyo, FR
    Ozores, R
    Lorenzo, L
    Rey, C
    Castro, A
    Solla, E
    Villascusa, R
    BONE MARROW TRANSPLANTATION, 1998, 21 : S57 - S57
  • [36] Repeated high-dose therapy with rituximab followed by autologous stem cell transplantation (ASCT) as primary treatment of high-risk aggressive NHL.
    Glass, B
    Kloess, M
    Engert, A
    Berdel, WE
    Metzner, B
    Truemper, LH
    Loeffler, M
    Pfreundschuh, M
    Schmitz, N
    BLOOD, 2003, 102 (11) : 735A - 735A
  • [38] High-dose chemotherapy of ovarian cancer followed by bone marrow transplantation or peripheral blood stem cell support
    Wcislo, Gabriel
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2005, 9 (01): : 14 - 22
  • [39] Zevalin dose-escalation followed by high-dose BEAM and autologous peripheral blood progenitor cell (PBPC) transplant in non-Hodgkin's lymphoma: Early outcome results.
    Winter, JN
    Inwards, D
    Erwin, W
    Wiseman, G
    Rademaker, A
    Patron, DR
    Williams, S
    Tallman, M
    Mehta, J
    Singhal, S
    Micallef, I
    Multani, P
    Zimmer, M
    Smith, L
    Spies, S
    White, C
    Gordon, LI
    BLOOD, 2002, 100 (11) : 411A - 412A
  • [40] High-dose chemotherapy and autologous peripheral blood stem cell rescue in a patient with pleuropulmonary blastoma
    de Castro, CG
    de Almeida, SG
    Gregianin, LJ
    Loss, JF
    Rivero, LF
    Schwartsmann, G
    Brunetto, AL
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (01) : 78 - 81